article · ACS Omega
copies/μL in processed human urine, demonstrating clinically relevant sensitivity for noninvasive, multiplexed detection. However, use with a neat urine sample requires a processing step that may limit POC use. In our clinics in Kenya, we process samples nearby, and a fast molecular test that does not require thermocycling, with a turnaround time within the span of a typical prenatal visit, will positively impact our patients.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1021/acsomega.5c12022
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
